Cargando…

Protein-based vaccine as the booster dose for adults: evidence and beyond

Detalles Bibliográficos
Autores principales:	Shang, Lianhan, Cao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365310/ https://www.ncbi.nlm.nih.gov/pubmed/35963271 http://dx.doi.org/10.1016/S1473-3099(22)00447-9

Ejemplares similares

Adapted vaccine strategy: facing the persistent challenges of COVID-19
por: Shang, Lianhan, et al.
Publicado: (2023)

Guarding a city from the COVID-19 pandemic
por: Xu, Jiuyang, et al.
Publicado: (2020)

Viral pneumonia in China: from surveillance to response
por: Shang, Lianhan, et al.
Publicado: (2020)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023)

What a second booster dose of mRNA COVID-19 vaccines tells us
por: Loubet, Paul, et al.
Publicado: (2022)

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
por: Hung, Ivan F N, et al.
Publicado: (2021)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

COV-BOOST: evidence to support rapid booster deployment
por: Hall, Victoria, et al.
Publicado: (2021)

COVID-19 vaccine booster strategy: striving for best practice
por: Tanriover, Mine Durusu, et al.
Publicado: (2022)

COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
por: Hart, John D, et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
por: Attolico, Immacolata, et al.
Publicado: (2022)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Boosters appear effective, but are they always needed?
por: Reddy, K Srinath
Publicado: (2021)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Treatment of depression in older adults beyond fluoxetine
por: Wagner, Gabriela Arantes
Publicado: (2015)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
por: Otu, Akaninyene, et al.
Publicado: (2021)

COVID-19 boosters and building trust among UK minority ethnic communities
por: Nellums, Laura B, et al.
Publicado: (2022)

Rotavirus vaccine implementation: evidence to fill the gap?
por: Buttery, Jim P, et al.
Publicado: (2021)

Oculoplastic video-based telemedicine consultations: Covid-19 and beyond
por: Kang, Swan, et al.
Publicado: (2020)

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Beyond bar charts
por: Saxon, Emma
Publicado: (2015)

COVID-19 vaccines for children younger than 12 years: are we ready?
por: Zou, Xiaohui, et al.
Publicado: (2021)

Open questions - in brief: Beyond -omics, missing motor proteins, and getting from molecules to organisms
por: Benkovic, Stephen J, et al.
Publicado: (2013)

Hospital admissions due to COVID-19 in Scotland after one dose of vaccine
por: Dean, Natalie
Publicado: (2021)

Microbes and microbiomes in 2020 and beyond
por: Natarajan, Aravind, et al.
Publicado: (2020)

Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?
por: Iversen, Patrick L, et al.
Publicado: (2021)

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Integrated pneumonia surveillance: pandemics and beyond
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80obit4ocf5upmsh3d23u2llhq